Skip to main content
. Author manuscript; available in PMC: 2025 Aug 27.
Published in final edited form as: Semin Liver Dis. 2025 Mar 5;45(1):33–51. doi: 10.1055/a-2551-0724

Table 1.

HSC subtypes in the fibrotic PME.

HSC subtype Markers Functions References
Cytokine and growth factor enriched HSC (cyHSC) Lowly-activated HSC or Col1a1low. enriched in growth factors (e.g., Rspo3, Hgf) and cytokines (e.g., Cxcl12) Support hepatocyte survival and regeneration through growth factors and cytokines. Filliol, A. et al. 2022. [13]
Myofibroblastic HSC (myHSC) Highly-activated HSC Col1a1high express activation markers (e.g., Acta2) and ECM proteins (e.g., Col1a1). Remodel ECM, increase liver stiffness, and promote pro-tumorigenic changes in advanced fibrosis. Filliol, A. et al. 2022. [13]
Kostallari, E. et al. 2022. [195]
Krenkel, O. et al. 2019. [196]
Proliferative-HSC Ki67+ Top2a+ Actively dividing HSCs contributing to population HSC expansion Expand HSC populations and support fibrotic responses. Merens, V. et al. 2024. [19]
Senescent-HSC Cell cycle arrest genes (Cdkn1a/p21, Cdkn2a/p16), SA-βGal+, SASP markers, uPAR. Promote chronic inflammation, alter ECM remodeling, and contribute to fibrosis persistence Krizhanovsky V. et al. 2008[42]
Takahashi A. et al. 2018[43]
Burton DG. et al. 2014[44]
Yashaswini CN. et al. 2024[45]
Yoshimoto S, et al. 2013[46]
Lujambio A. et al. 2013[47]
Amor C. et al. 2020[48]
Li F. et al. 2020[49]